Physician profile
Idris Sayed Sharaf
NPI 1659454098
$7,344.31
in general payments reported to CMS, 2019-2025
47 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,521 · 2020: $739 · 2021: $657 · 2022: $977 · 2023: $802 · 2024: $1,010 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,361 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,361.12 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $774.90 | 2019-2025 | Repatha |
| Pfizer INC. | $661.08 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $658.94 | 2019-2025 | |
| Boston Scientific Corporation | $488.11 | 2019-2025 | Watchman Flx, Cds Broad Portfolio Offering, General - Therapies |
| Actelion Pharmaceuticals US, INC. | $448.90 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Merck Sharp & Dohme LLC | $411.82 | 2021-2025 | Verquvo, Keytruda |
| Janssen Pharmaceuticals, INC | $404.81 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $355.47 | 2019-2025 | Wainua, Farxiga |
| Abbott Laboratories | $277.76 | 2019-2025 | Cardiomems, Mitraclip, Triclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.38 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $210.31 | 2019-2023 | |
| Lundbeck LLC | $196.84 | 2019-2020 | |
| Astellas Pharma US INC | $171.49 | 2020-2021 | |
| Abiomed | $165.28 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.43 | 2019-2024 | Lifevest |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $151.77 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Daiichi Sankyo INC. | $141.87 | 2019-2025 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $136.64 | 2021-2025 | Camzyos |
| Novo Nordisk INC | $128.55 | 2024-2025 | Wegovy |
| Amarin Pharma, INC. | $114.28 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.44 | 2022-2025 | |
| Bridgebio Pharma, INC. | $96.76 | 2025 | Attruby |
| Bracco Diagnostics INC. | $89.66 | 2024 | |
| Medtronic, INC. | $88.90 | 2021-2024 | Cobalt Dr Mri Surescan, Valiant Captivia, Corevalve Evolut R |
| Cvrx, INC. | $75.34 | 2022-2025 | Barostim Neo System |
| Arbor Pharmaceuticals, INC. | $72.89 | 2019-2021 | |
| Edwards Lifesciences Corporation | $54.92 | 2022-2025 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $44.31 | 2022-2024 | Onpattro |
| United Therapeutics Corporation | $38.50 | 2019-2022 | |
| Biotronik INC. | $31.35 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $30.33 | 2019 | |
| Bardy Diagnostics, INC. | $27.95 | 2022 | |
| Philips North America LLC | $26.67 | 2025 | Ecc Solutions |
| Medtronic Vascular, INC. | $25.99 | 2019-2020 | |
| Irhythm Technologies, INC. | $21.65 | 2019 | |
| Lantheus Medical Imaging, INC. | $18.91 | 2023 | Definity |
| Esperion Therapeutics, INC. | $17.17 | 2021 | |
| Scpharmaceuticals INC. | $16.88 | 2023 | |
| Stryker Corporation | $16.82 | 2025 | Clottriever Bold Catheter |
| Abbvie INC. | $16.75 | 2022 | |
| Solventum Corporation | $16.58 | 2025 | Promogran Prisma, Activ.A.C. |
| Baxter Healthcare | $15.05 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $14.93 | 2022 | |
| Azurity Pharmaceuticals, INC. | $13.54 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.00 | 2021 | |
| Vifor Pharma, INC. | $12.92 | 2020 | |
| Baylis Medical Company INC | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Idris Sharaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.